Need for differential discounting of costs and health effects in cost effectiveness analyses

Werner B.F. Brouwer; Louis W. Niessen; Maarten J. Postma; Frans F.H. Rutten

doi:10.1136/bmj.331.7514.446

Need for differential discounting of costs and health effects in cost effectiveness analyses

Werner B.F. Brouwer, Louis W. Niessen, Maarten J. Postma, Frans F.H. Rutten

Research output: Contribution to journal › Short survey › peer-review

162 Scopus citations

Abstract

New National Institute for Health and Clinical Excellence guidelines change the discount rates for costs and effects from 6% and 1.5% respectively to 3.5% for both. This change gives a lower weight to future health effects and may worsen the cost effectiveness ratio, especially for preventive interventions. Differential discounting is more appropriate when non-monetary outcomes like QALYs are used NICE should return to a 1.5% discount rate for effects.

Original language	English (US)
Pages (from-to)	446-448
Number of pages	3
Journal	British medical journal
Volume	331
Issue number	7514
DOIs	https://doi.org/10.1136/bmj.331.7514.446
State	Published - Aug 20 2005
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Access to Document

10.1136/bmj.331.7514.446

Cite this

@article{121a9197019f45ce99d0b8d3da08d377,

title = "Need for differential discounting of costs and health effects in cost effectiveness analyses",

abstract = "New National Institute for Health and Clinical Excellence guidelines change the discount rates for costs and effects from 6% and 1.5% respectively to 3.5% for both. This change gives a lower weight to future health effects and may worsen the cost effectiveness ratio, especially for preventive interventions. Differential discounting is more appropriate when non-monetary outcomes like QALYs are used NICE should return to a 1.5% discount rate for effects.",

author = "Brouwer, {Werner B.F.} and Niessen, {Louis W.} and Postma, {Maarten J.} and Rutten, {Frans F.H.}",

year = "2005",

month = aug,

day = "20",

doi = "10.1136/bmj.331.7514.446",

language = "English (US)",

volume = "331",

pages = "446--448",

journal = "British medical journal",

issn = "0959-8146",

publisher = "BMJ Publishing Group",

number = "7514",

}

TY - JOUR

T1 - Need for differential discounting of costs and health effects in cost effectiveness analyses

AU - Brouwer, Werner B.F.

AU - Niessen, Louis W.

AU - Postma, Maarten J.

AU - Rutten, Frans F.H.

PY - 2005/8/20

Y1 - 2005/8/20

N2 - New National Institute for Health and Clinical Excellence guidelines change the discount rates for costs and effects from 6% and 1.5% respectively to 3.5% for both. This change gives a lower weight to future health effects and may worsen the cost effectiveness ratio, especially for preventive interventions. Differential discounting is more appropriate when non-monetary outcomes like QALYs are used NICE should return to a 1.5% discount rate for effects.

AB - New National Institute for Health and Clinical Excellence guidelines change the discount rates for costs and effects from 6% and 1.5% respectively to 3.5% for both. This change gives a lower weight to future health effects and may worsen the cost effectiveness ratio, especially for preventive interventions. Differential discounting is more appropriate when non-monetary outcomes like QALYs are used NICE should return to a 1.5% discount rate for effects.

UR - http://www.scopus.com/inward/record.url?scp=23844453704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23844453704&partnerID=8YFLogxK

U2 - 10.1136/bmj.331.7514.446

DO - 10.1136/bmj.331.7514.446

M3 - Short survey

C2 - 16110075

AN - SCOPUS:23844453704

SN - 0959-8146

VL - 331

SP - 446

EP - 448

JO - British medical journal

JF - British medical journal

IS - 7514

ER -

Need for differential discounting of costs and health effects in cost effectiveness analyses

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this